Copyright Reports & Markets. All rights reserved.

Global Inosine Pranobex Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Inosine Pranobex Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Tablet
    • 1.3.3 Syrup
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Inosine Pranobex Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Immunomodulation
    • 1.4.3 Antiviral
    • 1.4.4 Other
  • 1.5 Global Inosine Pranobex Market Size & Forecast
    • 1.5.1 Global Inosine Pranobex Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Inosine Pranobex Sales Quantity (2020-2031)
    • 1.5.3 Global Inosine Pranobex Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Newport Pharmaceuticals
    • 2.1.1 Newport Pharmaceuticals Details
    • 2.1.2 Newport Pharmaceuticals Major Business
    • 2.1.3 Newport Pharmaceuticals Inosine Pranobex Product and Services
    • 2.1.4 Newport Pharmaceuticals Inosine Pranobex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Newport Pharmaceuticals Recent Developments/Updates
  • 2.2 Gedeon Richter
    • 2.2.1 Gedeon Richter Details
    • 2.2.2 Gedeon Richter Major Business
    • 2.2.3 Gedeon Richter Inosine Pranobex Product and Services
    • 2.2.4 Gedeon Richter Inosine Pranobex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Gedeon Richter Recent Developments/Updates
  • 2.3 Mochida
    • 2.3.1 Mochida Details
    • 2.3.2 Mochida Major Business
    • 2.3.3 Mochida Inosine Pranobex Product and Services
    • 2.3.4 Mochida Inosine Pranobex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Mochida Recent Developments/Updates
  • 2.4 Sanofi
    • 2.4.1 Sanofi Details
    • 2.4.2 Sanofi Major Business
    • 2.4.3 Sanofi Inosine Pranobex Product and Services
    • 2.4.4 Sanofi Inosine Pranobex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Sanofi Recent Developments/Updates
  • 2.5 Andrómaco
    • 2.5.1 Andrómaco Details
    • 2.5.2 Andrómaco Major Business
    • 2.5.3 Andrómaco Inosine Pranobex Product and Services
    • 2.5.4 Andrómaco Inosine Pranobex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Andrómaco Recent Developments/Updates
  • 2.6 Yung Shin
    • 2.6.1 Yung Shin Details
    • 2.6.2 Yung Shin Major Business
    • 2.6.3 Yung Shin Inosine Pranobex Product and Services
    • 2.6.4 Yung Shin Inosine Pranobex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Yung Shin Recent Developments/Updates
  • 2.7 Alfasigma S.p.A.
    • 2.7.1 Alfasigma S.p.A. Details
    • 2.7.2 Alfasigma S.p.A. Major Business
    • 2.7.3 Alfasigma S.p.A. Inosine Pranobex Product and Services
    • 2.7.4 Alfasigma S.p.A. Inosine Pranobex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Alfasigma S.p.A. Recent Developments/Updates
  • 2.8 Polfarmex
    • 2.8.1 Polfarmex Details
    • 2.8.2 Polfarmex Major Business
    • 2.8.3 Polfarmex Inosine Pranobex Product and Services
    • 2.8.4 Polfarmex Inosine Pranobex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Polfarmex Recent Developments/Updates
  • 2.9 Sanfer
    • 2.9.1 Sanfer Details
    • 2.9.2 Sanfer Major Business
    • 2.9.3 Sanfer Inosine Pranobex Product and Services
    • 2.9.4 Sanfer Inosine Pranobex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Sanfer Recent Developments/Updates
  • 2.10 Meprofarm
    • 2.10.1 Meprofarm Details
    • 2.10.2 Meprofarm Major Business
    • 2.10.3 Meprofarm Inosine Pranobex Product and Services
    • 2.10.4 Meprofarm Inosine Pranobex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Meprofarm Recent Developments/Updates
  • 2.11 Novell Pharmaceutical
    • 2.11.1 Novell Pharmaceutical Details
    • 2.11.2 Novell Pharmaceutical Major Business
    • 2.11.3 Novell Pharmaceutical Inosine Pranobex Product and Services
    • 2.11.4 Novell Pharmaceutical Inosine Pranobex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Novell Pharmaceutical Recent Developments/Updates
  • 2.12 Aflofarm
    • 2.12.1 Aflofarm Details
    • 2.12.2 Aflofarm Major Business
    • 2.12.3 Aflofarm Inosine Pranobex Product and Services
    • 2.12.4 Aflofarm Inosine Pranobex Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Aflofarm Recent Developments/Updates

3 Competitive Environment: Inosine Pranobex by Manufacturer

  • 3.1 Global Inosine Pranobex Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Inosine Pranobex Revenue by Manufacturer (2020-2025)
  • 3.3 Global Inosine Pranobex Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Inosine Pranobex by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Inosine Pranobex Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Inosine Pranobex Manufacturer Market Share in 2024
  • 3.5 Inosine Pranobex Market: Overall Company Footprint Analysis
    • 3.5.1 Inosine Pranobex Market: Region Footprint
    • 3.5.2 Inosine Pranobex Market: Company Product Type Footprint
    • 3.5.3 Inosine Pranobex Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Inosine Pranobex Market Size by Region
    • 4.1.1 Global Inosine Pranobex Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Inosine Pranobex Consumption Value by Region (2020-2031)
    • 4.1.3 Global Inosine Pranobex Average Price by Region (2020-2031)
  • 4.2 North America Inosine Pranobex Consumption Value (2020-2031)
  • 4.3 Europe Inosine Pranobex Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Inosine Pranobex Consumption Value (2020-2031)
  • 4.5 South America Inosine Pranobex Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Inosine Pranobex Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Inosine Pranobex Sales Quantity by Type (2020-2031)
  • 5.2 Global Inosine Pranobex Consumption Value by Type (2020-2031)
  • 5.3 Global Inosine Pranobex Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Inosine Pranobex Sales Quantity by Application (2020-2031)
  • 6.2 Global Inosine Pranobex Consumption Value by Application (2020-2031)
  • 6.3 Global Inosine Pranobex Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Inosine Pranobex Sales Quantity by Type (2020-2031)
  • 7.2 North America Inosine Pranobex Sales Quantity by Application (2020-2031)
  • 7.3 North America Inosine Pranobex Market Size by Country
    • 7.3.1 North America Inosine Pranobex Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Inosine Pranobex Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Inosine Pranobex Sales Quantity by Type (2020-2031)
  • 8.2 Europe Inosine Pranobex Sales Quantity by Application (2020-2031)
  • 8.3 Europe Inosine Pranobex Market Size by Country
    • 8.3.1 Europe Inosine Pranobex Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Inosine Pranobex Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Inosine Pranobex Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Inosine Pranobex Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Inosine Pranobex Market Size by Region
    • 9.3.1 Asia-Pacific Inosine Pranobex Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Inosine Pranobex Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Inosine Pranobex Sales Quantity by Type (2020-2031)
  • 10.2 South America Inosine Pranobex Sales Quantity by Application (2020-2031)
  • 10.3 South America Inosine Pranobex Market Size by Country
    • 10.3.1 South America Inosine Pranobex Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Inosine Pranobex Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Inosine Pranobex Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Inosine Pranobex Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Inosine Pranobex Market Size by Country
    • 11.3.1 Middle East & Africa Inosine Pranobex Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Inosine Pranobex Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Inosine Pranobex Market Drivers
  • 12.2 Inosine Pranobex Market Restraints
  • 12.3 Inosine Pranobex Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Inosine Pranobex and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Inosine Pranobex
  • 13.3 Inosine Pranobex Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Inosine Pranobex Typical Distributors
  • 14.3 Inosine Pranobex Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Inosine Pranobex market size was valued at US$ 216 million in 2024 and is forecast to a readjusted size of USD 250 million by 2031 with a CAGR of 2.1% during review period.
    Inosine pranobex (BAN; also known as inosine acedoben dimepranol (INN) or methisoprinol) an antiviral drug that is a combination of inosine and dimepranol acedoben (a salt of acetamidobenzoic acid and dimethylaminoisopropanol) in a ratio of 1 to 3. Inosine pranobex has no effect on viral particles itself. Instead, it acts as an immunostimulant, an analog of thymus hormones. It is most commonly used to treat the rare measles complication subacute sclerosing panencephalitis in conjunction with intrathecal interferon therapy.
    Global Inosine Pranobex key players include Newport Pharmaceuticals, Gedeon Richter, etc. Global top two manufacturers hold a share about 50%.
    Europe is the largest market, with a share about 55%, followed by North America and Japan, both have a share about 20 percent.
    In terms of product, Tablet is the largest segment, with a share about 70%. And in terms of application, the largest application is Antiviral, followed by Immunomodulation, etc.
    This report is a detailed and comprehensive analysis for global Inosine Pranobex market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Inosine Pranobex market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
    Global Inosine Pranobex market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
    Global Inosine Pranobex market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
    Global Inosine Pranobex market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Inosine Pranobex
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Inosine Pranobex market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Newport Pharmaceuticals, Gedeon Richter, Mochida, Sanofi, Andrómaco, Yung Shin, Alfasigma S.p.A., Polfarmex, Sanfer, Meprofarm, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Inosine Pranobex market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Tablet
    Syrup
    Market segment by Application
    Immunomodulation
    Antiviral
    Other
    Major players covered
    Newport Pharmaceuticals
    Gedeon Richter
    Mochida
    Sanofi
    Andrómaco
    Yung Shin
    Alfasigma S.p.A.
    Polfarmex
    Sanfer
    Meprofarm
    Novell Pharmaceutical
    Aflofarm
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Inosine Pranobex product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Inosine Pranobex, with price, sales quantity, revenue, and global market share of Inosine Pranobex from 2020 to 2025.
    Chapter 3, the Inosine Pranobex competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Inosine Pranobex breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Inosine Pranobex market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Inosine Pranobex.
    Chapter 14 and 15, to describe Inosine Pranobex sales channel, distributors, customers, research findings and conclusion.

    Buy now